European equities traded in the US as American depositary receipts were relatively flat Friday morning, edging 0.01% lower to 1,453.06 on the S&P Europe Select ADR Index, which ended the week up 1.4% and closed out the month nearly 4% higher.
From continental Europe, the gainers were led by accommodations booking company trivago (TRVG) and software firm SAP (SAP), which rose 2.4% and 1.7% respectively. They were followed by pharmaceutical company Novo Nordisk (NVO) and biopharmaceutical company Genfit (GNFT), which were up 1.2% and 0.9% respectively.
The decliners from continental Europe were led by pharmaceutical company Sanofi (SNY) and biotech firm BioNTech (BNTX), which fell 5.1% and 4.9% respectively. They were followed by telecommunications company Nokia (NOK) and semiconductor company Sequans Communications (SQNS), which lost 2.3% and 2.2% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Verona Pharma (VRNA) and pharmaceutical company GSK (GSK), which increased 2.6% and 2.3% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and utilities company National Grid (NGG), which advanced 1.9% and 1% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Bicycle Therapeutics (BCYC) and NuCana (NCNA), which dropped 3.8% and 3% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and biotech firm Autolus Therapeutics (AUTL), which were down 2.9% and 2.3% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。